Skip to main content
Full access
Clinical & Research News
Published Online: 1 July 2005

TADS Basics

The following is a brief summary of NIMH's Treatment of Adolescents with Depression Study (TADS), for which 12-week outcome data were published in the August 18, 2004, Journal of the American Medical Association.
Study Design: Randomized, blinded, multicenter comparing the effectiveness of four treatments for adolescent depression:
Cognitive-behavioral therapy (CBT) alone
Fluoxetine (Prozac) alone
Combination of CBT and fluoxetine
Placebo pill
Initial Outcomes: Percentage of the 439 adolescent patients who showed significant improvement at 12 weeks with a Clinical Global Impressions–Improvement score of 1 or 2:
CBT alone group: 43 percent
Fluoxetine alone group: 61 percent
Combination group: 71 percent
Placebo group: 34 percent

Information & Authors

Information

Published In

History

Published online: 1 July 2005
Published in print: July 1, 2005

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share